Denosumab Use in Chronic Kidney Disease Associated Osteoporosis: A Narrative Review

Chronic kidney disease (CKD) and hemodialysis (HD) patients have a high incidence of bone disease and increased fracture risk, making effective management of their bone health a clinical challenge. Denosumab, a human monoclonal antibody, has been investigated as a therapeutic option in this patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Abduelkarem, Abduelmula R, Guella, Adnane, Hamrouni, Amar M, Hassanein, Mohammed M, Nasr, Ahmed, Rana, Owais
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503558/
https://www.ncbi.nlm.nih.gov/pubmed/37719685
http://dx.doi.org/10.2147/RMHP.S426869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503558/
https://www.ncbi.nlm.nih.gov/pubmed/37719685
http://dx.doi.org/10.2147/RMHP.S426869

Ejemplares similares